KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aehr Test Systems (AEHR) Research & Development (2016 - 2026)

Aehr Test Systems filings provide 16 years of Research & Development readings, the most recent being $3.2 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 0.86% to $3.2 million in Q1 2026 year-over-year; TTM through Feb 2026 was $11.7 million, a 17.59% increase, with the full-year FY2025 number at $10.5 million, up 20.0% from a year prior.
  • Research & Development hit $3.2 million in Q1 2026 for Aehr Test Systems, up from $3.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $3.2 million in Q1 2026 to a low of $1.5 million in Q3 2022.
  • Median Research & Development over the past 5 years was $2.3 million (2023), compared with a mean of $2.3 million.
  • Biggest five-year swings in Research & Development: surged 69.32% in 2022 and later decreased 4.53% in 2024.
  • Aehr Test Systems' Research & Development stood at $1.6 million in 2022, then grew by 27.14% to $2.0 million in 2023, then grew by 15.42% to $2.3 million in 2024, then soared by 30.58% to $3.0 million in 2025, then rose by 6.56% to $3.2 million in 2026.
  • The last three reported values for Research & Development were $3.2 million (Q1 2026), $3.0 million (Q4 2025), and $2.8 million (Q3 2025) per Business Quant data.